BPG is committed to discovery and dissemination of knowledge
Citation
Han JH, Lu KR, Zhang M, Gong GH. Pristimerin attenuates spasmolytic polypeptide-expressing metaplasia via p57 (Cdkn1c)-mediated glycolytic reprogramming: A metabolic avenue for gastric cancer prevention. World J Gastroenterol 2026; 32(32): 118600 [DOI: 10.3748/wjg.118600]
Please LOGIN to submit a new comment.